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Supporting Figure 5 
Fig. 5. Graph depicting the cycling of the flow rates of the reagent and buffer 
streams to vary the concentration of the reagent in each plug. As the reagent 
stream flow rate is increased in 1.7-nl/s steps, the buffer stream is cycled out of 
phase to correspondingly decrease in 1.7-nl/s steps. This method keeps the total 
flow rate of the aqueous streams constant while changing the reagent concentration 
in each plug. 
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Supporting Figure 6 
Fig. 6. Relative plug size (plug length versus Teflon capillary inner diameter) as 
a function of water fraction (aqueous flow rate versus total flow rate). Three 
different viscosity solutions (∼1 mPa s to ∼6 mPa s to ∼36 mPa s) were tested, and 
all three showed linear dependence between relative plug sizes with changing water 
fraction. 
 
 
 
 
Supporting Figure 7 
Fig. 7. Standard dilution curves for (a) fluorscein in 10 mM Tris (pH 7.8) and 
0.05% (wt/vol) LDAO; (b) rhodamine B in 25% (wt/vol) PEG 8000 in 10 mM Tris (pH 
7.8) and 0.05% (wt/vol) LDAO; (c) PSS in 50% (wt/wt) glycerol in 10 mM Tris (pH 
7.8) and 0.05% (wt/vol) LDAO. 
 
 
 
 
Supporting Figure 8 
Fig. 8. Channel design for the hybrid device. (a) The AutoCAD mask design used to 
generate silicon masters is shown. The AutoCAD file is also provided as part of the 
supporting information. The dotted square is drawn around one of the channel 
designs, and a schematic of the channel with dimensions is shown in b, where 
dimensions of the different junctions of the device are provided. 
 
 
 
 
Supporting Figure 9 
Fig. 9. Dispensing submicroliter volumes of membrane protein solutions with no 
losses. (a) A schematic of protein solution in Teflon capillary filled with 
fluorinated carrier fluid and connected to a syringe. (b) A microphotograph of 0.8 
µl of rhodopsin with 0.1% LDAO as the detergent in Teflon capillary (350 µm, i.d.) 
shown next to a 10-µl syringe. 
 
 
 
 
Supporting Figure 10 
Page 2 of 12Nanoliter microfluidic hybrid method for simultaneous screening and optimization validat...
3/4/2007http://www.pnas.org/cgi/content/full/0607502103/DC1
Fig. 10. ΣA-weighted 2Fo-Fc electron-density map depicted at 1.4 σ level around the 
selected regions of the RC structure refined at 1.96-Å resolution. (a) HEME C, 
residue 401 C. (b) Ubiquinone-1, second binding site, residue 503 L. (c) 1,2,3-
heptanetriol, residue 705 U, bound to subunit H residues 124-126. 
 
 
 
 
Supporting Figure 11 
Fig. 11. Flow chart illustrating the procedures of the hybrid method. 
 
 
 
 
Table 1. Solubility of solutes in fluorinated amines 
Chemical name  F.w.  
Solubility of solutes in fluorinated 
amines, mol/liter)* 
FC40  FC70  
LDAO 229.4  None  None  
OG  292.4  None  None  
DDM 510.6  None  None  
Deriphat 160C  351.5  None  None  
1,2,3 
heptanetriol  148.2  None  None  
1,2,3-
hexanetriol 134.2  None  None  
Myo-inositol 180.2  None  None  
Ethylene 
glycol  62.07  None  None  
2R,3R 
butanediol  90.12  3.5 ?10-4 
 3.90 ?10-4  
Ethanol 46.06  8.50 ?10-3 4.70 ?10-3 
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*None indicates the solute was not detectable by NMR, suggesting a solubility well 
below 10-4 mol/liter. 
 
 
 
 
Table 2. Screening Conditions for Crystallizing Porin from R. Capsulatus 
Isopropanol 60.10  7.05 ?10-3 7.60 ?10-3 
MPD  118.2  6.50 ?10-3  2.30 ?10-3  
Number Precipitant Salt Buffer/pH 
3  10% wt/vol PEG 4000  0.2 M ammonium 
sulfate  
0.1 M sodium 
acetate trihydrate 
pH 4.6  
6  1.0 M ammonium 
sulfate  
  0.1 M sodium 
acetate trihydrate 
pH 4.6  
10  12% wt/vol PEG 6000  0.1 M sodium 
chloride  
0.1 M sodium 
acetate trihydrate 
pH 4.6  
17  12% wt/vol PEG 4000  0.1 M sodium 
chloride  
0.1 M tri-sodium 
citrate dihydrate 
pH 5.6  
21  4% vt/vol PEG 400  0.1 M lithium 
sulfate 
monohydrate  
0.1 M tri-sodium 
citrate dihydrate 
pH 5.6  
31  18% vol/vol PEG 400  0.1 M 
magnesium 
chloride 
hexahydrate  
0.1 M Hepes-sodium 
pH 7.5  
39  0.1 M potassium 
sodium tartrate  
0.1 M lithium 
sulfate 
monohydrate  
0.1 M Hepes-sodium 
pH 7.5  
*  70.6% PEG 550MME  3 M LiCl  150 mM Tris pH 8.0  
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Condition numbers are from Membfac screening kit from Hampton Research. 
*Condition prepared from known condition (6). 
 
 
 
 
Table 3. Screening conditions for crystallizing RC condition numbers are from a 
custom-made screening kit from deCode Biostructures 
Number  Buffer/pH  Precipitant  Salt  
1  
125.000 mM 
NaAc/acetic acid pH 
4.5  
22.500% wt/vol 
PEG 6000  187.500 mM NaCl  
2  
125.000 mM 
NaAc/acetic acid pH 
4.5  
22.500% wt/vol 
PEG 6000  187.500 mM MgCl2  
3  
125.000 mM tri-sodium 
citrate/citric acid 
pH 5.5  
22.500% wt/vol 
PEG 6000  187.500 mM lithium sulfate  
4  125.000 mM ADA/NaOH pH 6.5  
22.500% wt/vol 
PEG 6000  187.500 mM MgCl2 
 
5  125.000 mM Tris稨Cl/HCl pH 8.5  
22.500% wt/vol 
PEG 6000  
187.500 mM di-
ammonium phosphate  
6  
125.000 mM 
NaAc/acetic acid pH 
4.5  
22.500% wt/vol 
PEG 4000  187.500 mM ZnAc2  
7  
125.000 mM 
NaAc/acetic acid pH 
4.5  
18.750% wt/vol 
PEG 4000  
375.000 mM di-
ammonium sulfate  
8  
125.000 mM 
NaAc/acetic acid pH 
4.5  
22.500% wt/vol 
PEG 4000  
  
9  
125.000 mM Tri-sodium 
citrate/citric acid 
pH 5.5  
22.500% wt/vol 
PEG 4000  187.500 mM lithium sulfate  
10  125.000 mM Tri-sodium citrate/citric acid 
22.500% wt/vol 
PEG 4000  187.500 mM NaCl  
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*Condition prepared from known condition (4, 5). 
?/SUP>Modified condition at higher pH.
 
 
 
 
 
Table 4. Data collection and refinement statistics 
pH 5.5  
13  
125.000 mM Hepes 
sodium salt/HCl pH 
7.5  
18.750% wt/vol 
PEG 4000  
187.500 mM ammonium 
sulfate  
15  125.000 mM Tri-sodium 
citrate/citric acid 
pH 5.5  
33.750% 
vol/vol PEG 
400  
187.500 mM NaCl  
18  125.000 mM Tris 
HCl/HCl pH 8.5  
  2500.000 mM 
ammonium sulfate  
29  125.000 mM 
NaAc/acetic acid pH 
4.5  
  1875.000 mM 
magnesium sulfate  
30  125.000 mM Tri-sodium 
citrate/citric acid 
pH 5.5  
  1875.000 mM 
magnesium sulfate  
31  125.000 mM ADA/NaOH 
pH 6.5  
  187.500 mM lithium 
sulfate 1875.000 mM 
magnesium sulfate  
*  1.0 M di-sodium 
phosphate pH 6.0  
  4 M ammonium 
sulfate  
? 50mM Tris pH 7.8    3.6 M ammonium sulfate  
Data collection  Microfluidic hybrid 
method 
Space group  P43212  
Cell dimensions   
a, b, c, Å  220.4, 220.4,113.0  
α, β, γ, ? 90, 90, 90  
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Supporting Text 
Chemicals and Reagents. All solvents and salts used in buffers purchased from commercial sources 
were used as received unless otherwise stated. Tris(hydroxymethyl)aminomethane (Tris base) and 
fluorscein (disodium salt) were obtained from Fisher Scientific. Rhodamine B and PSS (1,3,6,8-
pyrenetetrasulfonic acid, tetra sodium) were obtained from Acros Organics. PEG 8000 was obtained 
from Fluka Biochemika. Lauryldimethylamine oxide (LDAO), n-dodecyl-β-D-maltopyranoside, and octyl-β-
D-glucopyranoside detergents were obtained from Anatrace. PEG 550MME and paraffin oil were obtained 
from Hampton Research. (tridecafluoro-1,1,2,2,-tetrahydrooctyl)-1 trichlorosilane was obtained from 
United Chemical Technologies. Poly(dimethylsiloxane) (PDMS, Sylgard 184 Silicone Elastomer kit) was 
obtained from Dow Corning. FC-40 (a mixture of perfluoro-tri-n-butylamine and perfluoro-di-
nbutylmethylamine) and FC-70 (perfluorotripentylamine) were obtained from 3M. The absorption inks 
were blue, red, and green ink from Conway Stewart. Teflon capillaries (OD 250 µm, i.d. 200 µm) were 
received from Zeus. Thirty-gauge Teflon tubing was obtained from Weico Wire & Cable. The standard 
wall glass tubing was obtained from Chemglass. Gastight syringes were obtained from Hamilton 
Company. 
Resolution, Å  50-1.96 (2.0-1.96)  
Rmerge  0.082 (0.48)  
I/σI  17.5 (2.3)  
Completeness, %  94.5 (67.4)  
Redundancy 5.9 (4.1)  
Refinement   
Resolution, Å  20-1.96  
No. of 
reflections  
189,189  
Rwork/Rfree  0.172/0.186  
No. of atoms   
Protein  9,293  
Ligand 790  
Fe/Mg/SO4 ions  5/4/13  
Water  771  
B-factors   
Protein  24.5  
Ligand 27.1  
Fe/Mg/SO4 ions  20.1/15.9/43.4  
Water  33.1  
rmsds    
Bond lengths, Å  0.008  
Bond angles, ? 1.330  
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PDMS Device Fabrication. PDMS was used to fabricate all microfluidic devices. Microchannels with 
rectangular cross-sections were fabricated with rapid prototyping (1). The hybrid microfluidic 
devices consisted of PDMS microchannels (cross-section: 250 µm by 250 µm) with three tapered inlets 
(100 µm by 250 µm) for aqueous phases and one orthogonal inlet for carrier fluid to form nanoliter 
plugs. The channel walls were functionalized with (tridecafluoro1,1,2,2-tetrahydrooctyl)-1-
trichlorosilane to render them hydrophobic and fluorophilic (2). 
Preparing Preformed Arrays. All input arrays were aspirated by using a manual microsyringe pump with 
glass syringes 10 or 50 µl in volume (3). Arrays were aspirated into Teflon capillary (O.D. 250 µm, 
i.d. 200 µm, length ∼10 cm), which was sealed to 30-gauge Teflon tubing by using capillary wax. 
Thirty-gauge Teflon tubing was connected to the syringe with a removable 27-gauge needle. The 
syringe and Teflon tubing were filled with FC-40. The input array was generated by aspirating ∼120-
140 nl of a reagent in alternation with ∼40 nl of air as the gas spacer. The aspirated cartridge was 
interfaced with the hybrid devices and sealed to the inlet with capillary wax. Preformed arrays were 
used within 30 min of aspiration. 
Standardization of Hybrid Concentration Gradient. To quantify on-chip dilution, fluorescence of 0.10 
mM fluorscein in 10 mM Tris (pH 7.8) and 0.05% (wt/vol) LDAO, 0.10 mM rhodamine B, 25% (wt/vol) PEG 
8000 in 10 mM Tris (pH 7.8) and 0.05% (wt/vol) LDAO, and 0.10 mM PSS, 50% (wt/wt) glycerol in 10 mM 
Tris (pH 7.8) and 0.05% (wt/vol) LDAO at six dilutions was measured (100%, 80%, 60%, 40%, 20%, and 
0% fluorescent solution). The dilutions were made by using a stock solution of 10 mM Tris (pH 7.8) 
and 0.05% LDAO (wt/vol). Plugs of these six solutions were aspirated into Teflon capillary (O.D. 250 
µm, i.d. 200 µm, length ∼10 cm) that was sealed to 30-gauge Teflon tubing by using a manual 
microsyringe pump with a glass syringe 50 µl in volume. Fluorescent solutions (∼25-nl plugs) were 
aspirated in duplicate, alternating with FC-40 (∼25-nl plugs), for a total of 12 fluorescent plugs 
in the array. Once the array was complete, the Teflon capillary was detached from the syringe, 
sealed at both ends with capillary wax, and placed in a Petri dish filled with water to facilitate 
fluorescence measurements. Fluorescence intensity of plugs was recorded by using a Leica DMI6000 
microscope (Leica Microsystems) with 10 × 0.4 Leica objective and Hamamatsu ORCAER camera. GFP, 
Texas red, and DAPI filters were used to collect fluorscein, rhodamine B, and PSS fluorescence, 
respectively. Images were acquired and analyzed with Metamorph imaging system version 6.3r1 
(Universal Imaging). Exposure times of 2, 3, and 150 ms were used for fluorscein, rhodamine B, and 
PSS. The baseline fluorescence intensity was taken of the buffer plugs (0% fluorescent solution) in 
each aspirated array. This baseline value was subtracted from the intensity of the fluorescent plugs 
to obtain the true intensity of each fluorescent dilution. 
Quantification of Hybrid Concentration Gradient. Concentration gradients of reagents in plugs were 
determined by measuring fluorescence intensity. The 0.10 mM fluorecein (Fisher Scientific), 0.10 mM 
1,3,6,8pyrenetetrasulfonic acid, tetra sodium (PSS; Acros Organics), and 0.10 mM rhodamine B (Acros 
Organics) were added to 10 mM Tris, pH 7.8 (viscosity ∼1 mPa s), 50% (wt/wt) glycerol in 10 mM Tris 
pH 7.8 (viscosity ∼6 mPa s), and 25% (wt/vol) PEG 8000 in 10 mM Tris, pH 7.8 (viscosity ∼36 mPa s), 
respectively. All solutions contained 0.05% (wt/vol) LDAO. The input array was generated by 
aspirating ∼140 nl of the reagents in alternation with ∼40 nl of air as the gas spacer. By using FC-
40 as the carrier fluid, the array was merged with two streams of buffer [0.05% (wt/vol) LDAO in 10 
mM Tris, pH 7.8]. The flow rates are given in the Fig. 1 legend and shown graphically in Fig. 5. 
After plugs were formed and flowed into a Teflon capillary, the flows were stopped, and the Teflon 
capillary was cut from the PDMS device and sealed with capillary wax on both ends. The Teflon 
capillary was placed in a Petri dish filled with water to facilitate fluorescence measurements. 
Fluorescence intensity of plugs was recorded by using a Leica DMI6000 microscope (Leica 
Microsystems) with 10 ×0.4 NA Leica objective and Hamamatsu ORCA-ER camera. GFP, Texas red, and DAPI 
filters were used to collect fluorescence of fluorscein, rhodamine B, and PSS, respectively. The 
size of each plug was measured under fluorescence. Images were acquired and analyzed with Metamorph 
imaging system version 6.3r1 (Universal Imaging). 
To form plugs containing different concentrations of reagents, the relative flow rates of the three 
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aqueous streams were changed to combine streams in several ratios. To index these concentrations, 
the sizes of plugs were simultaneously changed by altering the flow rate of the carrier fluid. 
The flow rates of both aqueous and carrier fluid streams were varied by using the Labview subroutine 
(available online at http://ismagilovlab.uchicago.edu/AutoCad_SI_2006_07502.dwg). The first buffer 
stream, made to mimic the substrate stream, was maintained at constant flow rate of 10 nl/s. The 
flow rate of the preformed plug array stream was cycled to first increase from 3.3 nl/s to 10 nl/s 
and then decrease from 10 nl/s to 3.3 nl/s with a step of 1.7 nl/s. Correspondingly, the second 
buffer stream was cycled to first decrease from 10 nl/s to 3.3 nl/s and then increase from 3.3 nl/s 
to 10 nl/s with a step of 1.7 nl/s. The flow rate of the carrier fluid was cycled to first increase 
from 23.3 nl/s to 50 nl/s and then decrease from 50 nl/s to 23.3 nl/sec with a step of 6.7 nl/s. 
Each flow rate step lasted for 1.5 s. The flow rate change of the carrier fluid was synchronous with 
the flow rate changes of the aqueous phases. 
To visualize the generation of the concentration gradient, the same setup as above was used, except 
instead of fluorscein, PSS, and rhodamine B, 50% (vol/vol) green ink (Conway Stewart, Plymouth, 
U.K.), 24% (vol/vol) blue ink (Conway Stewart), and 50% (vol/vol) red ink (Conway Stewart) were 
used, respectively. A diluting "buffer" stream of 0.05% LDAO in water and the membrane protein 
stream of ∼7 mg/ml reaction center (RC) from Rhodopseudomonas viridis in 0.05% (wt/vol) LDAO and 10 
mM Tris (pH 7.8) were merged with the stream of plugs from the preformed array. Images of plugs were 
taken with a Leica MZ 16 Stereoscope with a 1.0× objective. Images were collected with SPOT Advanced 
software (version 3.4.0 for windows). 
Loading Protein-Detergent Solution with no Dead Volume into a Syringe. We used a simple technique to 
minimize the volume of protein solution required to set up the experiment and to eliminate losses of 
the solution when filling syringes (Fig. 9). A 10-µl syringe connected to a piece of Teflon 
capillary was filled with the carrier fluid, and a small volume of the membrane protein solution was 
aspirated into the capillary. 
Crystallization of Reaction Center from R. viridis and Porin from Rhodobacter capsulatus 
 
For crystallization of RC from R. viridis, 16 precipitants were selected from a custom 
crystallization screening kit obtained from deCode Biostructures. In addition, we used two 
additional precipitants, both in duplicate (Table 3). The two precipitants were 4M (NH4)2SO4 in 50 
mM Na2HPO4/NaH2PO4 buffer (pH 6.0) based on the published condition (4; 5) and a modified condition 
at higher pH, 3.6 M (NH4)2SO4 in 50 mM Tris (pH 7.8). LDAO was added to precipitants from the kit at 
a concentration of 0.05% (wt/vol) and was added to the other two conditions at a concentration of 
0.15% (wt/vol). The reagent plugs were combined with the buffer stream of 0.15% (wt/vol) LDAO in 
Millipore water and the RC stream of 22 mg/ml RC, 0.08% LDAO, 7% heptane-triol, 4.5% 
triethylammonium phosphate solution in 20 mM Na2HPO4/NaH2PO4 buffer, pH 6.0. The crystallizing 
concentration of (NH4)2SO4 was 1.6-2.0 M for the pH 6.0 condition and 1.6-1.8 M for the pH 7.8 
condition. The experiment was performed in a low-light environment, and the crystals were kept in 
dark. Trials were incubated at 18°C. Micrographs of crystals were taken on a Leica MZ 16 
Stereoscope. The crystals that were photographed under bright-field illumination were not used for 
x-ray diffraction experiments. 
For Porin from R. capsulatus, eight precipitants were tested under seven conditions from MembFac 
(Hampton Research), and conditions 3, 6, 10, 17, 21, 31, and 39 (Table 2) were chosen. In addition, 
2% C8E4 (wt/vol), 3M LiCl, and 70.6% PEG 550MME in 150 mM Tris (pH 8.0) based on the published 
crystallization condition (6) was used. The reagent plugs were combined with the buffer stream of 
5.1% C8E4 in 150 mM Tris (pH 8.0) and the protein stream of 29.8 mg/ml Porin in 0.6% (wt/vol) n-
octyltetraoxyethylene (C8E4) and 20 mM Tris pH 7.8. The trials were incubated at 23°C. Crystals 
appeared only in the reported condition after 9 days of incubation at 23°C. Microphotographs of the 
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crystals were taken on a Leica MZ 16 Stereoscope with polarizer. 
Scaling-Up Experiments for Porin from R. capsulatus. Scaling-up experiments were performed by 
increasing the dimensions of microchannels. Instead of interfacing a Teflon capillary to the hybrid 
device, we inserted a large silanized glass capillary (O.D. 600 µm with wall thickness of 10 µm; 
Hampton Research) into the plug-forming junction. Once plugs were flowed into the glass capillaries, 
the end was removed from the PDMS device, and both ends were sealed with capillary wax. The sealed 
glass capillaries were placed in Petri dishes and incubated at 23°C. 
X-Ray Diffraction and Structure Determination. Crystals of RC grown by the hybrid microfluidic 
technique were extracted by attaching a syringe to one end of the Teflon capillaries and flowing the 
crystals slowly into a drop of paraffin oil (cryoprotectant) with the manual syringe driver. The 
plugs containing crystals could move >10 cm without sticking to the channel wall. This was 
accomplished in one of two ways. In both methods, the Teflon capillary with the crystals was 
attached to a 50 µl glass syringe. After that, the crystals could either be flowed out using a PHD 
2000 infusion syringe pump from Harvard Apparatus or a manual microsyringe pump. The maximum flow 
rate used to flow out crystals with the PHD 2000 syringe pump was 17 nl/s. The manual syringe pump 
allowed for easier control as well as precise flow of only one plug at a time. 
Once crystals were flowed into the cryoprotectant drop, the crystals were picked with a CryoLoop 
(Hampton Research) and flash-frozen in liquid nitrogen. The x-ray diffraction experiments were 
performed at GM/CA CAT station 23 ID-D of the Advanced Photon Source (Argonne National Laboratory). 
X-ray data were collected at 100 K by using a wavelength of 0.97943 Å, 2- or 3-second exposure 
times, and an oscillation width of 0.5°. The diffraction data were processed with HKL2000 (7). 
Because of small crystal size and substantial radiation damage, we had to merge x-ray data collected 
from two different crystals (25?oscillation range each) to obtain a complete (96.5%) data set with 
resolution of 1.96 Å. The RC crystals belong to space group P43211 with cell dimensions a = b = 
220.4 Å, c = 113 Å and were isomorphous to crystals reported earlier with PDB codes 1PRC (2.3 Å 
resolution) (8) and 1DXR (His-L168-Phe mutant, 2.0 Å resolution) (9). We used the 1DXR structure 
with corrected L168 residue as a starting model in our refinement. The rigid-body positional and 
temperature factor refinement was performed by using maximum-likelihood target with the program 
REFMAC5 (10). Rfree was monitored by setting aside 5% of the reflection as a test set. The ΣA-
weighted 2Fobs-Fcalc and Fobs-Fcalc Fourier maps were calculated by using CCP4 (11). The Fourier 
maps were displayed and examined in TURBO-FRODO (12). The search for new solvent molecules was 
performed with help of the ARP-WARP program (13). The crystal data, data collection, and refinement 
statistics are summarized in Table 4, and the example of electron-density maps are shown in Fig. 10. 
A Ramachandran plot calculated with PROCHECK (14) indicates that 99.7% of the non-Gly and non-Pro 
residues in the final models lie in the most-favored and additional-allowed regions. Our model 
contains 771 water molecules, 13 SO4
2- ions (because we used phosphate buffer in the 
crystallization, some of the ions can indeed be PO4
3- ions) and 3 molecules of 1,2,3-heptanetriol. 
In addition to the existing binding site reported in 1PCR, we have identified the second binding 
site of ubiquinone-1. As compared with 2.0-Å resolution 1DXR structure, we have identified 276 water 
molecules. Two thirds of the water molecules were found in the first hydration shell (cytochrome c: 
87 H2O, subunit H: 41 H2O, subunit L: 16 H2O, subunit M: 39 H2O). The rmsds for main-chain atoms 
calculated for our final model and previously reported structures 1PRC and 1DXR are 0.39 Å and 0.31 
Å, respectively. Figures showing the electron-density map and three-dimensional structures were 
prepared by using TURBO-FRODO (12) and RIBBONS (15). The coordinates and structure factors have been 
deposited in the Protein Data Bank with an entry code 2I5N. 
X-ray diffraction experiments with Porin were carried out at 4°C by using the in situ method (16-18) 
at GM/CA CAT station 23 ID-D of the Advanced Photon Source (Argonne National Laboratories). Porin 
crystals in Teflon capillary were flowed into silanized glass capillaries (200 µm; Hampton Research) 
by using a manual syringe pump. Crystals that were grown from scaling-up studies were already in 
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glass capillaries for direct diffraction studies. The diffraction experiments were performed with 2-
s exposure times. The first shots gave diffraction patterns at resolution at ∼ 1.95 Å. The 
diffraction decayed rapidly in six frames, preventing the collection of a full data set. The Porin 
crystals grown by microfluidic technique belong to space group H3 with cell dimensions a = b = 91.5 
Å, c = 146.3 Å and were isomorphous to ones reported earlier (6). 
Additional Control Experiments. Establishing plug size dependence on water fraction. We used the 
"water fraction" (19), the ratio of the combined volumetric flow rates of the aqueous streams to the 
total flow rate of the carrier fluid and the aqueous streams, to index the concentration of the 
reagent in plugs generated by using the hybrid method. As the computer subroutine increased the 
relative flow rate of the reagent stream, it also decreased the flow rate of the buffer to keep the 
combined volumetric flow rates of the three aqueous streams constant (Fig. 5). In sync with this 
cycle, the subroutine increased the flow rate of the carrier fluid (FC-40), thereby decreasing the 
water faction and decreasing the size of the plug. We were able to show that the size of plugs 
changes approximately linearly with water fraction, and we found the dependence to be slightly 
sensitive to viscosity (Fig. 6). 
Quantification of solubility of common precipitants in perfluroamine carrier fluids. To assess if 
any chemicals used to crystallize membrane proteins were being dissolved in the perfluroamine 
carrier fluids, we quantified the solubilities of some typical detergents and precipitants with NMR 
experiments (Table 1). 
In each case, the saturated solution was made first. We added 1% (wt/vol for solid and vol/vol for 
liquid) of the testing chemical to the carrier fluid (FC-40 or FC-70) in an Eppendorf tube. The tube 
was vortex-vibrated for one minute and then centrifuged (Eppendorf Centrifuge 5415D) at 10 krpm for 
10 min. The FC-40 or FC-70 phase was collected with a pipette. The NMR sample was then made by 
taking 40 µl of 5% (vol/vol) 1H, 1H, 2H, 2H-Perfluorooctanol (PFO) in FC-40 or FC-70 and mixing it 
with 200 µl of the saturated solution and 260 µl of FC-40 or FC-70. Four blank experiments were also 
performed: (i) 40 µl of 5% PFO in FC-40 + 460 µl of FC-40, (ii) 40 µl of 5% PFO in FC-70 + 460 µl of 
FC-70, (iii) 500 µl of FC-40, and (iv) 500 µl of FC-70. PFO was used as an internal standard. The 
concentration (solubility) of the testing chemical was determined with the internal standard (Table 
1). 
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